News Releases Sona Engages Clinical Trial Clinic for First-in-Human Early Feasibility Study of its THT Cancer Therapy
News Releases Sona Announces Successful Study Showing Absence of Endotoxins In Its Cancer Therapy Gold Nanorods Prior to First-in-human Clinical Trial
News Releases Sona Presents Additional Preclinical Data Demonstrating Repeated Ability Of Its Cancer Therapy To Inhibit Tumor Growth In Colorectal Cancer Model
News Releases Sona Nanotech to Present Targeted Hyperthermia Therapy at the 19th International Canadian Melanoma Conference
News Releases Sona Nanotech’s THT Cancer Therapy Preclinical Efficacy Studies Published In Peer-reviewed Scientific Journal
News Releases Sona Nanotech’s THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study
Webinars Join Sona Nanotech’s CEO, David Regan, and CMO, Dr. Carman Giacomantonio, December 11th 2024
News Releases Sona Nanotech to Showcase its THT Cancer Therapy at NCL 20th Anniversary Symposium and Provides Corporate Update
News Releases Sona Nanotech Closes Private Placement Financing to Raise $1,500,000 in Gross Proceeds and Announces Additional Financing